Compile Data Set for Download or QSAR
Report error Found 162 Enz. Inhib. hit(s) with Target = 'N-acetylglucosamine-1-phosphotransferase subunits alpha/beta'
TargetN-acetylglucosamine-1-phosphotransferase subunits alpha/beta(Human)
Merck Sharp & Dohme

US Patent
LigandChemical structure of BindingDB Monomer ID 519403BDBM519403((4S,5R)-5-[3,5- bis(trifluoromethyl) phenyl]-N-(2,...)
Affinity DataIC50: 10nMAssay Description:The TarO biochemical enzymatic assay is a liquid chromatography-mass spectroscopy (LC-MS) based end point assay that measures C55-P-P-GlcNAc (LIPID I...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/4/2022
Entry Details
US Patent

TargetN-acetylglucosamine-1-phosphotransferase subunits alpha/beta(Human)
Merck Sharp & Dohme

US Patent
LigandChemical structure of BindingDB Monomer ID 519343BDBM519343(US11141403, Example 58 | 3-[2-(4-tert- butylpiperi...)
Affinity DataIC50: 10nMAssay Description:The TarO biochemical enzymatic assay is a liquid chromatography-mass spectroscopy (LC-MS) based end point assay that measures C55-P-P-GlcNAc (LIPID I...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/4/2022
Entry Details
US Patent

TargetN-acetylglucosamine-1-phosphotransferase subunits alpha/beta(Human)
Merck Sharp & Dohme

US Patent
LigandChemical structure of BindingDB Monomer ID 519416BDBM519416((4S,5S)-5-[6-ethoxy- 4-(trifluoromethyl) pyridin-2...)
Affinity DataIC50: 10nMAssay Description:The TarO biochemical enzymatic assay is a liquid chromatography-mass spectroscopy (LC-MS) based end point assay that measures C55-P-P-GlcNAc (LIPID I...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/4/2022
Entry Details
US Patent

TargetN-acetylglucosamine-1-phosphotransferase subunits alpha/beta(Human)
Merck Sharp & Dohme

US Patent
LigandChemical structure of BindingDB Monomer ID 519419BDBM519419((4S,5R)-5-(3,5-bis(trifluoromethyl)phenyl)-3-(3-(i...)
Affinity DataIC50: 10nMAssay Description:The TarO biochemical enzymatic assay is a liquid chromatography-mass spectroscopy (LC-MS) based end point assay that measures C55-P-P-GlcNAc (LIPID I...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/4/2022
Entry Details
US Patent

TargetN-acetylglucosamine-1-phosphotransferase subunits alpha/beta(Human)
Merck Sharp & Dohme

US Patent
LigandChemical structure of BindingDB Monomer ID 519350BDBM519350((4S,5R)-5-[3,5- bis(trifluoromethyl)phenyl]- 4-met...)
Affinity DataIC50: 10nMAssay Description:The TarO biochemical enzymatic assay is a liquid chromatography-mass spectroscopy (LC-MS) based end point assay that measures C55-P-P-GlcNAc (LIPID I...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/4/2022
Entry Details
US Patent

TargetN-acetylglucosamine-1-phosphotransferase subunits alpha/beta(Human)
Merck Sharp & Dohme

US Patent
LigandChemical structure of BindingDB Monomer ID 519421BDBM519421((4S,5R)-5-[3,5- bis(trifluoromethyl) phenyl]-4-met...)
Affinity DataIC50: 10nMAssay Description:The TarO biochemical enzymatic assay is a liquid chromatography-mass spectroscopy (LC-MS) based end point assay that measures C55-P-P-GlcNAc (LIPID I...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/4/2022
Entry Details
US Patent

TargetN-acetylglucosamine-1-phosphotransferase subunits alpha/beta(Human)
Merck Sharp & Dohme

US Patent
LigandChemical structure of BindingDB Monomer ID 519351BDBM519351((4S,5R)-5-[3-fluoro-5- (trifluoromethyl)phenyl]- 4...)
Affinity DataIC50: 10nMAssay Description:The TarO biochemical enzymatic assay is a liquid chromatography-mass spectroscopy (LC-MS) based end point assay that measures C55-P-P-GlcNAc (LIPID I...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/4/2022
Entry Details
US Patent

TargetN-acetylglucosamine-1-phosphotransferase subunits alpha/beta(Human)
Merck Sharp & Dohme

US Patent
LigandChemical structure of BindingDB Monomer ID 519422BDBM519422((4S,5R)-3-[3-(1- benzothiophen-4- yl)propanoyl]-5-...)
Affinity DataIC50: 10nMAssay Description:The TarO biochemical enzymatic assay is a liquid chromatography-mass spectroscopy (LC-MS) based end point assay that measures C55-P-P-GlcNAc (LIPID I...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/4/2022
Entry Details
US Patent

TargetN-acetylglucosamine-1-phosphotransferase subunits alpha/beta(Human)
Merck Sharp & Dohme

US Patent
LigandChemical structure of BindingDB Monomer ID 519352BDBM519352((4S,5R)-5-[3,5- bis(trifluoromethyl)phenyl]- 4-met...)
Affinity DataIC50: 10nMAssay Description:The TarO biochemical enzymatic assay is a liquid chromatography-mass spectroscopy (LC-MS) based end point assay that measures C55-P-P-GlcNAc (LIPID I...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/4/2022
Entry Details
US Patent

TargetN-acetylglucosamine-1-phosphotransferase subunits alpha/beta(Human)
Merck Sharp & Dohme

US Patent
LigandChemical structure of BindingDB Monomer ID 518851BDBM518851(US11141403, Example 5 | 3-[5-bromo-2-(trans-4- eth...)
Affinity DataIC50: 10nMAssay Description:The TarO biochemical enzymatic assay is a liquid chromatography-mass spectroscopy (LC-MS) based end point assay that measures C55-P-P-GlcNAc (LIPID I...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/4/2022
Entry Details
US Patent

TargetN-acetylglucosamine-1-phosphotransferase subunits alpha/beta(Human)
Merck Sharp & Dohme

US Patent
LigandChemical structure of BindingDB Monomer ID 518864BDBM518864(US11141403, Example 7 | N-cyclohexyl-N-ethyl- 3-[2...)
Affinity DataIC50: 10nMAssay Description:The TarO biochemical enzymatic assay is a liquid chromatography-mass spectroscopy (LC-MS) based end point assay that measures C55-P-P-GlcNAc (LIPID I...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/4/2022
Entry Details
US Patent

TargetN-acetylglucosamine-1-phosphotransferase subunits alpha/beta(Human)
Merck Sharp & Dohme

US Patent
LigandChemical structure of BindingDB Monomer ID 519070BDBM519070(US11141403, Example 47 | N-cyclohexyl-N-ethyl- 3-{...)
Affinity DataIC50: 10nMAssay Description:The TarO biochemical enzymatic assay is a liquid chromatography-mass spectroscopy (LC-MS) based end point assay that measures C55-P-P-GlcNAc (LIPID I...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/4/2022
Entry Details
US Patent

TargetN-acetylglucosamine-1-phosphotransferase subunits alpha/beta(Human)
Merck Sharp & Dohme

US Patent
LigandChemical structure of BindingDB Monomer ID 519402BDBM519402((4S,5R)-5-[3-fluoro-5- (trifluoromethyl)phenyl]- N...)
Affinity DataIC50: 10nMAssay Description:The TarO biochemical enzymatic assay is a liquid chromatography-mass spectroscopy (LC-MS) based end point assay that measures C55-P-P-GlcNAc (LIPID I...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/4/2022
Entry Details
US Patent

TargetN-acetylglucosamine-1-phosphotransferase subunits alpha/beta(Human)
Merck Sharp & Dohme

US Patent
LigandChemical structure of BindingDB Monomer ID 519354BDBM519354((4S,5R)-N-[2- (difluoromethoxy) benzyl]-5-[3-fluor...)
Affinity DataIC50: 20nMAssay Description:The TarO biochemical enzymatic assay is a liquid chromatography-mass spectroscopy (LC-MS) based end point assay that measures C55-P-P-GlcNAc (LIPID I...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/4/2022
Entry Details
US Patent

TargetN-acetylglucosamine-1-phosphotransferase subunits alpha/beta(Human)
Merck Sharp & Dohme

US Patent
LigandChemical structure of BindingDB Monomer ID 519355BDBM519355((4S,5R)-5-[3-fluoro-5- (trifluoromethyl)phenyl]- 4...)
Affinity DataIC50: 20nMAssay Description:The TarO biochemical enzymatic assay is a liquid chromatography-mass spectroscopy (LC-MS) based end point assay that measures C55-P-P-GlcNAc (LIPID I...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/4/2022
Entry Details
US Patent

TargetN-acetylglucosamine-1-phosphotransferase subunits alpha/beta(Human)
Merck Sharp & Dohme

US Patent
LigandChemical structure of BindingDB Monomer ID 518860BDBM518860(US11141403, Example 6 | N-cyclohexyl-N-ethyl- 3-(2...)
Affinity DataIC50: 20nMAssay Description:The TarO biochemical enzymatic assay is a liquid chromatography-mass spectroscopy (LC-MS) based end point assay that measures C55-P-P-GlcNAc (LIPID I...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/4/2022
Entry Details
US Patent

TargetN-acetylglucosamine-1-phosphotransferase subunits alpha/beta(Human)
Merck Sharp & Dohme

US Patent
LigandChemical structure of BindingDB Monomer ID 519033BDBM519033(US11141403, Example 44 | N-cyclohexyl-N-ethyl- 3-{...)
Affinity DataIC50: 20nMAssay Description:The TarO biochemical enzymatic assay is a liquid chromatography-mass spectroscopy (LC-MS) based end point assay that measures C55-P-P-GlcNAc (LIPID I...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/4/2022
Entry Details
US Patent

TargetN-acetylglucosamine-1-phosphotransferase subunits alpha/beta(Human)
Merck Sharp & Dohme

US Patent
LigandChemical structure of BindingDB Monomer ID 519349BDBM519349((4S,5R)-5-(3,5-bis(trifluoromethyl)phenyl)-N-(isoq...)
Affinity DataIC50: 30nMAssay Description:The TarO biochemical enzymatic assay is a liquid chromatography-mass spectroscopy (LC-MS) based end point assay that measures C55-P-P-GlcNAc (LIPID I...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/4/2022
Entry Details
US Patent

TargetN-acetylglucosamine-1-phosphotransferase subunits alpha/beta(Human)
Merck Sharp & Dohme

US Patent
LigandChemical structure of BindingDB Monomer ID 519453BDBM519453((4S,5R)-5-[3- (dimethylamino)-5- (trifluoromethyl)...)
Affinity DataIC50: 30nMAssay Description:The TarO biochemical enzymatic assay is a liquid chromatography-mass spectroscopy (LC-MS) based end point assay that measures C55-P-P-GlcNAc (LIPID I...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/4/2022
Entry Details
US Patent

TargetN-acetylglucosamine-1-phosphotransferase subunits alpha/beta(Human)
Merck Sharp & Dohme

US Patent
LigandChemical structure of BindingDB Monomer ID 519406BDBM519406((4S,5R)-5-[3,5- bis(trifluoromethyl) phenyl]-N-(2,...)
Affinity DataIC50: 30nMAssay Description:The TarO biochemical enzymatic assay is a liquid chromatography-mass spectroscopy (LC-MS) based end point assay that measures C55-P-P-GlcNAc (LIPID I...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/4/2022
Entry Details
US Patent

TargetN-acetylglucosamine-1-phosphotransferase subunits alpha/beta(Human)
Merck Sharp & Dohme

US Patent
LigandChemical structure of BindingDB Monomer ID 519356BDBM519356((4S,5R)-5-[3-fluoro-5- (trifluoromethyl)phenyl]- 4...)
Affinity DataIC50: 30nMAssay Description:The TarO biochemical enzymatic assay is a liquid chromatography-mass spectroscopy (LC-MS) based end point assay that measures C55-P-P-GlcNAc (LIPID I...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/4/2022
Entry Details
US Patent

TargetN-acetylglucosamine-1-phosphotransferase subunits alpha/beta(Human)
Merck Sharp & Dohme

US Patent
LigandChemical structure of BindingDB Monomer ID 519357BDBM519357((4S,5R)-5-[3-fluoro-5- (trifluoromethyl)phenyl]- N...)
Affinity DataIC50: 30nMAssay Description:The TarO biochemical enzymatic assay is a liquid chromatography-mass spectroscopy (LC-MS) based end point assay that measures C55-P-P-GlcNAc (LIPID I...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/4/2022
Entry Details
US Patent

TargetN-acetylglucosamine-1-phosphotransferase subunits alpha/beta(Human)
Merck Sharp & Dohme

US Patent
LigandChemical structure of BindingDB Monomer ID 518870BDBM518870(US11141403, Example 8 | 3-[6-bromo-2-(trans-4- eth...)
Affinity DataIC50: 30nMAssay Description:The TarO biochemical enzymatic assay is a liquid chromatography-mass spectroscopy (LC-MS) based end point assay that measures C55-P-P-GlcNAc (LIPID I...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/4/2022
Entry Details
US Patent

TargetN-acetylglucosamine-1-phosphotransferase subunits alpha/beta(Human)
Merck Sharp & Dohme

US Patent
LigandChemical structure of BindingDB Monomer ID 518872BDBM518872(US11141403, Example 9 | N-cyclohexyl-N-ethyl- 3-[2...)
Affinity DataIC50: 30nMAssay Description:The TarO biochemical enzymatic assay is a liquid chromatography-mass spectroscopy (LC-MS) based end point assay that measures C55-P-P-GlcNAc (LIPID I...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/4/2022
Entry Details
US Patent

TargetN-acetylglucosamine-1-phosphotransferase subunits alpha/beta(Human)
Merck Sharp & Dohme

US Patent
LigandChemical structure of BindingDB Monomer ID 519447BDBM519447((5R,6S)-6-(3,5-bis(trifluoromethyl)phenyl)-N-(isoq...)
Affinity DataIC50: 30nMAssay Description:The TarO biochemical enzymatic assay is a liquid chromatography-mass spectroscopy (LC-MS) based end point assay that measures C55-P-P-GlcNAc (LIPID I...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/4/2022
Entry Details
US Patent

TargetN-acetylglucosamine-1-phosphotransferase subunits alpha/beta(Human)
Merck Sharp & Dohme

US Patent
LigandChemical structure of BindingDB Monomer ID 518968BDBM518968(US11141403, Example 34 | N-cyclohexyl-N-ethyl- 3-{...)
Affinity DataIC50: 40nMAssay Description:The TarO biochemical enzymatic assay is a liquid chromatography-mass spectroscopy (LC-MS) based end point assay that measures C55-P-P-GlcNAc (LIPID I...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/4/2022
Entry Details
US Patent

TargetN-acetylglucosamine-1-phosphotransferase subunits alpha/beta(Human)
Merck Sharp & Dohme

US Patent
LigandChemical structure of BindingDB Monomer ID 519423BDBM519423((4S,5R)-4-methyl-3-(3- naphthalen-1- ylpropanoyl)-...)
Affinity DataIC50: 40nMAssay Description:The TarO biochemical enzymatic assay is a liquid chromatography-mass spectroscopy (LC-MS) based end point assay that measures C55-P-P-GlcNAc (LIPID I...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/4/2022
Entry Details
US Patent

TargetN-acetylglucosamine-1-phosphotransferase subunits alpha/beta(Human)
Merck Sharp & Dohme

US Patent
LigandChemical structure of BindingDB Monomer ID 519358BDBM519358((4S,5R)-N-[3- (dimethylamino)benzyl]- 5-[3-fluoro-...)
Affinity DataIC50: 40nMAssay Description:The TarO biochemical enzymatic assay is a liquid chromatography-mass spectroscopy (LC-MS) based end point assay that measures C55-P-P-GlcNAc (LIPID I...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/4/2022
Entry Details
US Patent

TargetN-acetylglucosamine-1-phosphotransferase subunits alpha/beta(Human)
Merck Sharp & Dohme

US Patent
LigandChemical structure of BindingDB Monomer ID 519445BDBM519445((4S,5R)-5- [3,5- bis(trifluoro- methyl) phenyl]-4-...)
Affinity DataIC50: 40nMAssay Description:The TarO biochemical enzymatic assay is a liquid chromatography-mass spectroscopy (LC-MS) based end point assay that measures C55-P-P-GlcNAc (LIPID I...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/4/2022
Entry Details
US Patent

TargetN-acetylglucosamine-1-phosphotransferase subunits alpha/beta(Human)
Merck Sharp & Dohme

US Patent
LigandChemical structure of BindingDB Monomer ID 518875BDBM518875(US11141403, Example 10 | N-cyclohexyl-N-ethyl- 3-[...)
Affinity DataIC50: 40nMAssay Description:The TarO biochemical enzymatic assay is a liquid chromatography-mass spectroscopy (LC-MS) based end point assay that measures C55-P-P-GlcNAc (LIPID I...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/4/2022
Entry Details
US Patent

TargetN-acetylglucosamine-1-phosphotransferase subunits alpha/beta(Human)
Merck Sharp & Dohme

US Patent
LigandChemical structure of BindingDB Monomer ID 518876BDBM518876(US11141403, Example 11 | N-cyclohexyl-N-ethyl- 3-[...)
Affinity DataIC50: 40nMAssay Description:The TarO biochemical enzymatic assay is a liquid chromatography-mass spectroscopy (LC-MS) based end point assay that measures C55-P-P-GlcNAc (LIPID I...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/4/2022
Entry Details
US Patent

TargetN-acetylglucosamine-1-phosphotransferase subunits alpha/beta(Human)
Merck Sharp & Dohme

US Patent
LigandChemical structure of BindingDB Monomer ID 518927BDBM518927(US11141403, Example 25 | N-cyclohexyl-N-ethyl- 3-[...)
Affinity DataIC50: 50nMAssay Description:The TarO biochemical enzymatic assay is a liquid chromatography-mass spectroscopy (LC-MS) based end point assay that measures C55-P-P-GlcNAc (LIPID I...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/4/2022
Entry Details
US Patent

TargetN-acetylglucosamine-1-phosphotransferase subunits alpha/beta(Human)
Merck Sharp & Dohme

US Patent
LigandChemical structure of BindingDB Monomer ID 519359BDBM519359((4S,5R)-5-[3,5-bis (trifluoromethyl)phenyl]- 4-met...)
Affinity DataIC50: 50nMAssay Description:The TarO biochemical enzymatic assay is a liquid chromatography-mass spectroscopy (LC-MS) based end point assay that measures C55-P-P-GlcNAc (LIPID I...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/4/2022
Entry Details
US Patent

TargetN-acetylglucosamine-1-phosphotransferase subunits alpha/beta(Human)
Merck Sharp & Dohme

US Patent
LigandChemical structure of BindingDB Monomer ID 519360BDBM519360((4S,5R)-N-(2,3- dihydro-1,4- benzodioxin-5- ylmeth...)
Affinity DataIC50: 50nMAssay Description:The TarO biochemical enzymatic assay is a liquid chromatography-mass spectroscopy (LC-MS) based end point assay that measures C55-P-P-GlcNAc (LIPID I...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/4/2022
Entry Details
US Patent

TargetN-acetylglucosamine-1-phosphotransferase subunits alpha/beta(Human)
Merck Sharp & Dohme

US Patent
LigandChemical structure of BindingDB Monomer ID 518966BDBM518966(US11141403, Example 33 | 3-[2-(cis-4-tert-butylcyc...)
Affinity DataIC50: 60nMAssay Description:The TarO biochemical enzymatic assay is a liquid chromatography-mass spectroscopy (LC-MS) based end point assay that measures C55-P-P-GlcNAc (LIPID I...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/4/2022
Entry Details
US Patent

TargetN-acetylglucosamine-1-phosphotransferase subunits alpha/beta(Human)
Merck Sharp & Dohme

US Patent
LigandChemical structure of BindingDB Monomer ID 519437BDBM519437((4S,5R)-5-[3,5- bis(trifluoromethyl) phenyl]-4-eth...)
Affinity DataIC50: 60nMAssay Description:The TarO biochemical enzymatic assay is a liquid chromatography-mass spectroscopy (LC-MS) based end point assay that measures C55-P-P-GlcNAc (LIPID I...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/4/2022
Entry Details
US Patent

TargetN-acetylglucosamine-1-phosphotransferase subunits alpha/beta(Human)
Merck Sharp & Dohme

US Patent
LigandChemical structure of BindingDB Monomer ID 519361BDBM519361((4S,5R)-5-[3-fluoro-5- (trifluoromethyl)phenyl]- N...)
Affinity DataIC50: 60nMAssay Description:The TarO biochemical enzymatic assay is a liquid chromatography-mass spectroscopy (LC-MS) based end point assay that measures C55-P-P-GlcNAc (LIPID I...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/4/2022
Entry Details
US Patent

TargetN-acetylglucosamine-1-phosphotransferase subunits alpha/beta(Human)
Merck Sharp & Dohme

US Patent
LigandChemical structure of BindingDB Monomer ID 518877BDBM518877(tert-butyl 3-(1-{3- [cyclohexyl(ethyl) amino]-3-ox...)
Affinity DataIC50: 60nMAssay Description:The TarO biochemical enzymatic assay is a liquid chromatography-mass spectroscopy (LC-MS) based end point assay that measures C55-P-P-GlcNAc (LIPID I...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/4/2022
Entry Details
US Patent

TargetN-acetylglucosamine-1-phosphotransferase subunits alpha/beta(Human)
Merck Sharp & Dohme

US Patent
LigandChemical structure of BindingDB Monomer ID 519415BDBM519415((4S,5S)-N-(isoquinolin- 4-ylmethyl)-4-methyl- 2-ox...)
Affinity DataIC50: 60nMAssay Description:The TarO biochemical enzymatic assay is a liquid chromatography-mass spectroscopy (LC-MS) based end point assay that measures C55-P-P-GlcNAc (LIPID I...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/4/2022
Entry Details
US Patent

TargetN-acetylglucosamine-1-phosphotransferase subunits alpha/beta(Human)
Merck Sharp & Dohme

US Patent
LigandChemical structure of BindingDB Monomer ID 518969BDBM518969(US11141403, Example 35 | N-cyclohexyl-3-(2- cycloh...)
Affinity DataIC50: 70nMAssay Description:The TarO biochemical enzymatic assay is a liquid chromatography-mass spectroscopy (LC-MS) based end point assay that measures C55-P-P-GlcNAc (LIPID I...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/4/2022
Entry Details
US Patent

TargetN-acetylglucosamine-1-phosphotransferase subunits alpha/beta(Human)
Merck Sharp & Dohme

US Patent
LigandChemical structure of BindingDB Monomer ID 519035BDBM519035(US11141403, Example 45 | butyl 3-(1-{3- [cyclohexy...)
Affinity DataIC50: 70nMAssay Description:The TarO biochemical enzymatic assay is a liquid chromatography-mass spectroscopy (LC-MS) based end point assay that measures C55-P-P-GlcNAc (LIPID I...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/4/2022
Entry Details
US Patent

TargetN-acetylglucosamine-1-phosphotransferase subunits alpha/beta(Human)
Merck Sharp & Dohme

US Patent
LigandChemical structure of BindingDB Monomer ID 519424BDBM519424((4S,5R)-5-[3-fluoro-5- (trifluoromethyl)phenyl]- 3...)
Affinity DataIC50: 80nMAssay Description:The TarO biochemical enzymatic assay is a liquid chromatography-mass spectroscopy (LC-MS) based end point assay that measures C55-P-P-GlcNAc (LIPID I...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/4/2022
Entry Details
US Patent

TargetN-acetylglucosamine-1-phosphotransferase subunits alpha/beta(Human)
Merck Sharp & Dohme

US Patent
LigandChemical structure of BindingDB Monomer ID 519408BDBM519408((4S,5R)-5-[3,5- bis(trifluoromethyl) phenyl]-4- (h...)
Affinity DataIC50: 80nMAssay Description:The TarO biochemical enzymatic assay is a liquid chromatography-mass spectroscopy (LC-MS) based end point assay that measures C55-P-P-GlcNAc (LIPID I...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/4/2022
Entry Details
US Patent

TargetN-acetylglucosamine-1-phosphotransferase subunits alpha/beta(Human)
Merck Sharp & Dohme

US Patent
LigandChemical structure of BindingDB Monomer ID 519020BDBM519020(US11141403, Example 43 | N-cyclohexyl-N-ethyl-3-(2...)
Affinity DataIC50: 80nMAssay Description:The TarO biochemical enzymatic assay is a liquid chromatography-mass spectroscopy (LC-MS) based end point assay that measures C55-P-P-GlcNAc (LIPID I...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/4/2022
Entry Details
US Patent

TargetN-acetylglucosamine-1-phosphotransferase subunits alpha/beta(Human)
Merck Sharp & Dohme

US Patent
LigandChemical structure of BindingDB Monomer ID 519052BDBM519052(US11141403, Example 46 | N-cyclohexyl-N-ethyl- 3-{...)
Affinity DataIC50: 80nMAssay Description:The TarO biochemical enzymatic assay is a liquid chromatography-mass spectroscopy (LC-MS) based end point assay that measures C55-P-P-GlcNAc (LIPID I...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/4/2022
Entry Details
US Patent

TargetN-acetylglucosamine-1-phosphotransferase subunits alpha/beta(Human)
Merck Sharp & Dohme

US Patent
LigandChemical structure of BindingDB Monomer ID 519072BDBM519072(US11141403, Example 48 | N-cyclohexyl-N-ethyl- 3-[...)
Affinity DataIC50: 90nMAssay Description:The TarO biochemical enzymatic assay is a liquid chromatography-mass spectroscopy (LC-MS) based end point assay that measures C55-P-P-GlcNAc (LIPID I...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/4/2022
Entry Details
US Patent

TargetN-acetylglucosamine-1-phosphotransferase subunits alpha/beta(Human)
Merck Sharp & Dohme

US Patent
LigandChemical structure of BindingDB Monomer ID 519345BDBM519345(US11141403, Example 60 | 3-{2-[(4-tert-butylpiperi...)
Affinity DataIC50: 100nMAssay Description:The TarO biochemical enzymatic assay is a liquid chromatography-mass spectroscopy (LC-MS) based end point assay that measures C55-P-P-GlcNAc (LIPID I...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/4/2022
Entry Details
US Patent

TargetN-acetylglucosamine-1-phosphotransferase subunits alpha/beta(Human)
Merck Sharp & Dohme

US Patent
LigandChemical structure of BindingDB Monomer ID 519362BDBM519362((4S,5R)-N-(2- ethoxybenzyl)-5-[3- fluoro-5- (trifl...)
Affinity DataIC50: 100nMAssay Description:The TarO biochemical enzymatic assay is a liquid chromatography-mass spectroscopy (LC-MS) based end point assay that measures C55-P-P-GlcNAc (LIPID I...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/4/2022
Entry Details
US Patent

TargetN-acetylglucosamine-1-phosphotransferase subunits alpha/beta(Human)
Merck Sharp & Dohme

US Patent
LigandChemical structure of BindingDB Monomer ID 519074BDBM519074(US11141403, Example 49 | propyl 5-(1-{3- [cyclohex...)
Affinity DataIC50: 110nMAssay Description:The TarO biochemical enzymatic assay is a liquid chromatography-mass spectroscopy (LC-MS) based end point assay that measures C55-P-P-GlcNAc (LIPID I...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/4/2022
Entry Details
US Patent

TargetN-acetylglucosamine-1-phosphotransferase subunits alpha/beta(Human)
Merck Sharp & Dohme

US Patent
LigandChemical structure of BindingDB Monomer ID 518883BDBM518883(US11141403, Example 18 | Ethyl 3-(1-{3- [cyclohexy...)
Affinity DataIC50: 110nMAssay Description:The TarO biochemical enzymatic assay is a liquid chromatography-mass spectroscopy (LC-MS) based end point assay that measures C55-P-P-GlcNAc (LIPID I...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/4/2022
Entry Details
US Patent

Displayed 1 to 50 (of 162 total ) | Next | Last >>
Jump to: